| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $64.3M | +28.1% |
| Cost of Revenue | $9.1M | +16.9% |
| Gross Profit | $55.2M | +30.2% |
| R&D Expense | $20.4M | -2.2% |
| SG&A Expense | $33.2M | +17.2% |
| Operating Income | -$56.6M | -32.7% |
| Interest Expense | $5.4M | +369.0% |
| Pre-tax Income | -$61.8M | -75.0% |
| Income Tax | $54K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.1M | -36.5% |
| Short-term Investments | $21.8M | -67.4% |
| Accounts Receivable | $11.8M | +53.8% |
| Inventory | $7.3M | +29.9% |
| Current Assets | $57.0M | -45.2% |
| Total Assets | $79.7M | -28.6% |
| Current Liabilities | $20.2M | +52.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$48.9M | -28.7% |
| Capital Expenditures | $9.2M | +564.1% |
| Investing Cash Flow | $37.4M | +2225.0% |
| Financing Cash Flow | $3.5M | -91.3% |
| Free Cash Flow | -$58.1M | -47.5% |
| -18.2% |
| Net Income | -$61.8M | -74.8% |
| EPS (Basic) | -$2.39 | -270.7% |
| EPS (Diluted) | -$2.39 | -270.7% |
| Long-term Debt |
| $42.2M |
| +6.1% |
| Total Liabilities | $75.0M | +21.1% |
| Stockholders' Equity | $4.5M | -90.8% |